Previous Page  9 / 28 Next Page
Information
Show Menu
Previous Page 9 / 28 Next Page
Page Background

Page 44

Notes:

conferenceseries

.com

Volume 08

Journal of Alzheimers Disease & Parkinsonism

Alzheimer's Congress 2018

May 30-31, 2018

May 30-31, 2018 Osaka, Japan

10

th

World Congress on

Alzheimer's Disease & Dementia

Accelerated brain aging with relevance to type 3 diabetes and alzheimer’s disease

Ian James Martins

Edith Cowan University, Australia

T

he main constituent of plaques in the brain of Alzheimer’s Disease (AD) individuals namely Amyloid beta (Aβ) is a

proteolytic product of a larger protein the Amyloid Precursor Protein (APP) protein. Carriers of the apo E4 allele are

at greater risk of developing AD with increased deposition of amyloid-beta plaques in western countries. Protein and Aβ

homeostasis is now crucial to the lifespan of organisms and is an important feature that determines the aging process in

obesity, diabetes and neurodegenerative diseases. The scientific understanding of the maintenance of peripheral blood plasma

Aβ and caffeine metabolism has now become essential to prevent neurodegeneration that is linked to type-3 diabetes. The

concentration of Aβ within the brain is determined by hepatic Aβ clearance and interest in the liver has increased markedly

since in western countries the incidence of Non-Alcoholic Fatty Liver Disease (NAFLD) and insulin resistance has reached

approx. 20% of the developed world. Induction of type-3 diabetes is related to delayed hepatic caffeine metabolism (NAFLD)

with circadian dysynchrony (type-3 diabetes) connected to defective peripheral hepatic caffeine and Aβ metabolism. Healthy

diets stabilize type-3 diabetes and maintain the circadian rhythm with relevance to brain insulin resistance and alzheimer’s

disease.

Biography

Ian James Martins is an Editor and Reveiwer for Open Acess Pub/MDPI journals. He has appointed as the Chief Editor for

International Journal of Diabetes

Research

(2014-2018);

Research and Reviews: Neuroscience

(2016-2018) and

Journal of Diabetes and Clinical

Studies (2017-2018); Scientist for Science

Advisory Board (USA) and Academic with

Academia.edu.

He also has Lifetime Membership by International Agency for Standards and Ratings as Fellow; Winner

of World Academic Championship-2017 in Diabetes and Medical Science (Nutrition).

i.martins@ecu.edu.au

Ian James Martins, J Alzheimers Dis Parkinsonism 2018, Volume 8

DOI: 10.4172/2161-0460-C4-046